Earnings
Neutral
3 Reasons IEP is Risky and 1 Stock to Buy Instead
Breaking news from global financial markets
2 months ago
Read More
2 months ago
888
2 months ago
2,526
2 months ago
1,655
2 months ago
4,348
2 months ago
666
2 months ago
4,332
2 months ago
2,482
2 months ago
2,626
2 months ago
2,018
2 months ago
4,952
2 months ago
4,060
2 months ago
2,612
2 months ago
3,076
2 months ago
1,638
FDA Accepts Rhythm Pharma' SNDA For Setmelanotide To Treat Acquired Hypothalamic Obesity
Regulations
2 months ago
2,036
2 months ago
3,790
2 months ago
607
Trending Now
1
Alcon reaffirms $10.3B–$10.4B 2025 sales outlook as Unity VCS and new launches d...
1,824
25 minutes ago
2
Oakmark Global Concentrated Strategy buys DASTY; exits CNC
21,551
25 minutes ago
3
Finning sees sustained $1B power systems backlog as product support revenue clim...
24,149
26 minutes ago
4
Evolution Petroleum outlines capital-light mineral acquisition strategy while ma...
44,484
26 minutes ago
5
HAProxy Technologies Launches HAProxy Unified Gateway to Simplify Kubernetes Tra...
48,348
29 minutes ago